New Options (or not) for Treatment of Idiopathic Intracranial Hypertension
- 25 March 2022
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 22 (4) , 257-264
Abstract
Purpose of review Idiopathic intracranial hypertension (IIH) is a disorder primarily affecting obese women of childbearing age and, if left untreated, can lead to irreversible vision loss. No consensus exists on the best management strategy for IIH. Weight loss is advocated and few useful medical options exist. There is an unmet need to discover new treatment options for this increasingly prevalent condition. This article reviews the recent advances and research on the treatment of IIH. Recent findings Venous sinus stenting (VSS) is now performed in many experienced centers, and there is growing interest in bariatric surgery as a treatment modality. Newly approved anti-obesity drugs are showing effectiveness in weight loss, and novel targeted disease-modifying IIH therapies are being explored. Summary Further evaluation of these novel therapeutic strategies as well as studies exploring the use of anti-obesity drugs in IIH is needed. While VSS is gaining popularity due to its efficacy and low complication rate, there is insufficient evidence to support any surgical procedure over another. Bariatric surgery is appealing for patients with non-sight-threatening IIH and needs to be further explored.Keywords
Funding Information
- National Institutes of Health (P30EY010572)
- Research to Prevent Blindness (Unrestricted grant)
This publication has 45 references indexed in Scilit:
- Cerebrospinal Fluid Secretion by the Choroid PlexusPhysiological Reviews, 2013
- Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertensionJournal of NeuroInterventional Surgery, 2011
- Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year reviewCephalalgia, 2011
- Effect of Optic Nerve Sheath Fenestration on Papilledema of the Operated and the Contralateral Nonoperated Eyes in Idiopathic Intracranial HypertensionOphthalmology, 2011
- Bariatric surgery for the treatment of idiopathic intracranial hypertensionJournal of Neurosurgery, 2011
- Cerebrospinal Fluid Corticosteroid Levels and Cortisol Metabolism in Patients with Idiopathic Intracranial Hypertension: A Link between 11β-HSD1 and Intracranial Pressure Regulation?The Journal of Clinical Endocrinology & Metabolism, 2010
- Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label studyActa Neurologica Scandinavica, 2007
- Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertensionNeurosurgical Focus, 2007
- Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstemNeuroscience, 1997
- Cerebral venography and manometry in idiopathic intracranial hypertensionNeurology, 1995